Analysis of a single nucleotide polymorphism in codon 388 of the FGFR4 gene in malignant gliomas

Cancer Letters

Volumn 239, Issue 2, 2006, Pages 239-245

  Mawrin, Christian ^a   Kirches, Elmar ^a   Diete, Sabine ^a   Wiedemann, Falk R ^a   Schneider, Thomas ^a   Firsching, Raimund ^a   Kropf, Siegfried ^a   Bogerts, Bernhard ^a   Vorwerk, Christian K ^a   Krüger, Sabine ^a   Dietzmann, Knut ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

FGFR4; Glioblastoma multiforme; Survival

Indexed keywords

ARGININE; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GLYCINE;

ADULT; ARTICLE; ASTROCYTOMA; CANCER CELL CULTURE; CANCER INVASION; CANCER SURGERY; CARCINOGENESIS; CODON; CONTROLLED STUDY; FEMALE; FREQUENCY ANALYSIS; GENETIC ANALYSIS; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUSCLE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR;

BASE SEQUENCE; BRAIN NEOPLASMS; CELL LINE, TUMOR; CODON; DNA PRIMERS; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4;

EID: 33745668196     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.08.013     Document Type: Article

References (15)

1. Legler J.M., Ries L.A., Smith M.A., Warren J.L., Heineman E.F., Kaplan R.S., and Linet M.S. Cancer surveillance series: brain and other central nervous system cancers: recent trends in incidence and mortality. J. Natl. Cancer Inst. 91 (1991) 1382-1390
2. Asher R., and Bignami A. Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes. Exp. Cell. Res. 203 (1992) 80-90
3. Ylagan L.R., and Quinn B. CD44 expression in astrocytic tumors. Mod. Pathol. 10 (1997) 1239-1246
4. Nakano A., Tani E., Miyazaki K., Yamamoto Y., and Furuyama J. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J. Neurosurg. 83 (1995) 298-307
5. Leins A., Riva P., Lindstedt R., Davidoff M.S., Mehraein P., and Weis S. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Cancer 98 (2003) 2430-2439
6. Oz B., Karayel F.A., Gazio N.L., Ozlen F., and Balci K. The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas. Pathol. Oncol. Res. 6 (2000) 118-124
7. Burke D., Wilkes D., Blundell T.L., and Malcolm S. Fibroblast growth factor receptors: lessons from the genes. Trends Biochem. Sci. 23 (1998) 59-62
8. Bange J., Prechtl D., Cheburkin Y., Specht K., Harbeck N., Schmitt M., et al. Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. Cancer Res. 62 (2002) 840-847
9. Streit S., Bange J., Fichtner A., Ihrler S., Issing W., and Ullrich A. Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma. Int. J. Cancer 111 (2004) 213-217
10. Morimoto Y., Ozaki T., Ouchida M., Umehara N., Ohata N., Yoshida A., et al. Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma. Cancer 98 (2003) 2245-2250
11. Jezequel P., Campion L., Joalland M.P., Millour M., Dravet F., Classe J.M., et al. G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis. Br. J. Cancer 90 (2004) 189-193
12. Yamada S.M., Yamada S., Hayashi Y., Takahashi H., Teramoto A., and Matsumoto K. Fibroblast growth factor receptor (FGFR) 4 correlated with the malignancy of human astrocytomas. J. Neurooncol. 24 (2002) 244-248
13. Cavenee W.K., Furnari F.B., Nagane M., Huang H.J.S., Newcomb E.W., Bigner D.D., et al. Astrocytic tumours. In: Kleihues P., and Cavenee W. (Eds). Pathology and Genetics (2000), Tumours of the Nervous System, International Agency for Cancer Research, Lyon 9-39
14. Ezzat S., Zheng L., Zhu X.F., Wu G.E., and Asa S.L. Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. J. Clin. Invest. 109 (2002) 69-78
15. Shah R.N., Ibbitt J.C., Alitalo K., and Hurst H. FGFR4 overexpression in pancreatic cancer is mediated by an intronic enhancer activated by HNF1alpha. Oncogene 21 (2002) 8251-8261